Careers  |  Sign In  |  Register

Latest in Pharmacists

The SMART study demonstrated that CD4-guided intermittent ART was inferior to continuous ART for major clinical outcomes. References and Resources retroconference.org Sponsored by The Doctor's...
The results of a phase II, multicenter trial that included 25 adult patients with newly diagnosed disease reported that patients maintained a complete response to treatment with high-dose methotrexate alone for a primary central nervous system lymphoma. References and Resources Gerstner E, et al. ...

No significant difference in primary endpoint

ENHANCE: Ezetimibe Plus Simvastatin versus Simvastatin Alone

ENHANCE was a surrogate endpoint trial conducted in 720 patients with Heterozygous Familial Hypercholesterolemia. This study showed no significant difference in the primary endpoint between patients treated with ezetimibe plus simvastatin versus patients treated with simvastatin alone over a two-year...